Oleanolic acid suppresses pentylenetetrazole-induced seizure in vivo

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Epileptic seizures are a neurological disorder characterized by recurrent seizures.
• Pentylenetetrazole (PTZ) is a common chemoconvulsant used to induce seizures in animal models.
• Oxidative stress plays a significant role in the pathophysiology of epilepsy.

Purpose of the Study:

• To investigate the neuroprotective effects of oleanolic acid against PTZ-induced epileptic seizures in mice.
• To evaluate the impact of oleanolic acid on antioxidant enzyme activity and levels in the brain.
• To assess the potential of oleanolic acid as an adjunctive therapy for epilepsy.

Main Methods:

• Male Swiss albino mice were divided into five groups: control, PTZ-induced seizures, and three groups pretreated with varying doses of oleanolic acid (10, 30, 100 mg/kg).
• Seizure latency, duration, and severity scores were recorded after PTZ administration.
• Brain tissue was analyzed for antioxidant enzyme activity (catalase, acetylcholinesterase) and levels (glutathione, superoxide dismutase).

Main Results:

• PTZ injection induced significant seizures compared to the control group.
• Oleanolic acid pretreatment significantly increased seizure latency and decreased seizure duration and scores.
• Oleanolic acid administration led to increased brain antioxidant enzyme activity (CAT, AChE) and levels (GSH, SOD).

Conclusions:

• Oleanolic acid exhibits significant anticonvulsant properties in a PTZ-induced epilepsy model.
• The compound demonstrates potential in mitigating oxidative stress associated with seizures.
• These findings suggest oleanolic acid may be a promising therapeutic agent for epilepsy treatment, potentially preventing cognitive disturbances.